SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-027051
Filing Date
2023-02-07
Accepted
2023-02-07 17:05:59
Documents
1
Group Members
JONATHAN A. FLINTPOLARIS VENTURE MANAGEMENT CO. IV, L.L.C.POLARIS VENTURE MANAGEMENT CO. V, L.L.C.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND IV, L.P.POLARIS VENTURE PARTNERS ENTREPRENEURS FUND V, L.P.POLARIS VENTURE PARTNERS FOUNDERS FUND V, L.P.POLARIS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d372712dsc13ga.htm SC 13G/A 159714
  Complete submission text file 0001193125-23-027051.txt   162006
Mailing Address 480 ARSENAL WAY WATERTOWN MA 02472
Business Address 480 ARSENAL WAY WATERTOWN MA 02472 617-373-4600
Lyra Therapeutics, Inc. (Subject) CIK: 0001327273 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91508 | Film No.: 23595983
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210
Business Address ONE MARINA PARK DRIVE 10TH FLOOR BOSTON MA 02210 781-290-0770
Polaris Venture Partners V, L.P. (Filed by) CIK: 0001439590 (see all company filings)

IRS No.: 204234825 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A